Company intelligence / Profile preview

Borayer Biotechnology

Ownership: Private
Development stage: Commercial

Overview

Borayer is a platform-based R&D company specializing in high-end consumables and biomaterials for clinical applications such as rapid wound healing. The company develops and markets advanced wound closure devices and related medical products. Some products are already available commercially; others are under development or evaluation. No detailed public clinical trial results were found.

Therapeutic areas: OtherDermatology
Modalities: BiomaterialMedical deviceWound care product
Industry: Consumable Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Borayer Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Borayer Biotechnology.

Explore the full profile